INTERNATIONAL PATENT: SYNTEKABIO, INC., (주)신테카바이오 FILES APPLICATION FOR "COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS, COMPRISING CRENOLANIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF"

GENEVA, June 3 -- SYNTEKABIO, INC. (1903ho, 1 Expo-ro,Yuseong-gu,Daejeon 34126), (주)신테카바이오 (대전광역시유성구엑스포로 1, 1903호) filed a patent application (PCT/KR2024/018409) for "COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS, COMPRISING CRENOLANIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF" on Nov 20, 2024. With publication no. WO/2025/110717, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Invent...